46,676 Shares in CVS Health Corporation $CVS Acquired by AG2R LA Mondiale Gestion D Actifs

Key Points

• AG2R LA Mondiale Gestion D Actifs has acquired 46,676 shares of CVS Health Corporation, valued at approximately $2.99 million, indicating strong institutional interest in the company.
• CVS Health reported a quarterly earnings per share (EPS) of $1.81, exceeding expectations by $0.35, and achieved revenue of $98.92 billion, up 8.4% year-over-year.
• The company declared a quarterly dividend of $0.665, representing a 3.5% annual yield, with a dividend payout ratio of 74.30%.

AG2R LA Mondiale Gestion D Actifs acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 46,676 shares of the pharmacy operator's stock, valued at approximately $2,989,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in shares of CVS Health by 0.8% in the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock valued at $8,017,223,000 after acquiring an additional 969,027 shares during the last quarter. Dodge & Cox raised its position in shares of CVS Health by 4.8% during the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator's stock valued at $4,976,856,000 after acquiring an additional 3,353,223 shares during the last quarter. Invesco Ltd. raised its position in shares of CVS Health by 13.2% during the 1st quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock valued at $1,383,039,000 after acquiring an additional 2,375,764 shares during the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of CVS Health by 14.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator's stock valued at $1,037,205,000 after acquiring an additional 1,942,886 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of CVS Health by 5.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock worth $924,643,000 after purchasing an additional 728,924 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Insider Buying and Selling

In related news, Director Anne A. Finucane sold 7,500 shares of the business's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at $1,573,519.12. The trade was a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.22% of the stock is currently owned by insiders.

CVS Health Stock Up 0.4%

Shares of CVS traded up $0.33 on Friday, reaching $75.00. The company's stock had a trading volume of 6,400,711 shares, compared to its average volume of 6,810,735. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $75.55. The stock has a market capitalization of $95.12 billion, a PE ratio of 20.95, a PEG ratio of 0.83 and a beta of 0.62. The firm has a fifty day moving average of $67.11 and a 200-day moving average of $66.33.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same period in the prior year, the firm posted $1.83 EPS. The firm's quarterly revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Equities analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 1st. Investors of record on Tuesday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Tuesday, July 22nd. CVS Health's payout ratio is presently 74.30%.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. Robert W. Baird upgraded CVS Health from a "neutral" rating to an "outperform" rating and increased their target price for the stock from $71.00 to $82.00 in a report on Thursday, August 14th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $67.00 to $79.00 in a research report on Monday, August 18th. Cowen reiterated a "buy" rating on shares of CVS Health in a research note on Monday, August 4th. Zacks Research cut CVS Health from a "strong-buy" rating to a "hold" rating in a research note on Monday, September 8th. Finally, Bernstein Bank decreased their price objective on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating on the stock in a research note on Wednesday, July 16th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, CVS Health currently has a consensus rating of "Moderate Buy" and an average target price of $77.89.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.